Opinion of SÚKL's Department of Clinical Trials on Medicinal Products on Ongoing Clinical Trials and To-Be-Commenced Clinical Trials in Light of the COVID-19 Epidemiological Situation of 22 December 2020

Opinion of SÚKL – 22. 12. 2020- eng final.pdf

Please see the highlighted changes in the PDF document:
Opinion of SÚKL – 22. 12. 2020- eng with revision.pdf

The new COVID-19 terms:

the new COVID-19 terms_cze
the new COVID-19 terms_eng

Updated Guidance version 3:

Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic released by EMA and GCP IWG, version 3, dated 28.4.2020

 

Department of Clinical Trials on Medicinal Products

Date: 23 December 2020

Archive: 

16.03.2020 Opinion of SÚKL´s OKH on ongoing CT

 20.03.2020 Opinion of SÚKL´s OKH on ongoing CT

 03.04.2020 Opinion of SÚKL´s OKH on ongoing CT

 06.04.2020 Opinion of SÚKL´s OKH on ongoing CT

 23.04.2020 Opinion of SÚKL´s OKH on ongoing CT

 14.05.2020 Opinion of SÚKL´s OKH on ongoing CT

 25.06.2020 Opinion of SÚKL´s OKH on ongoing CT

 01.07.2020 Opinion of SÚKL´s OKH on ongoing CT

 28.08.2020 Opinion of SÚKL´s OKH on ongoing CT

 06.11.2020 Opinion of SÚKL´s OKH on ongoing CT